Dr. Swaminath interested in clinical and translational aspects of inflammatory bowel disease, specifically the intersection of diet, medications, microbiota in patients with Crohn's and Colitis.
Research training opportunities for residents and fellows:
- Systematic review of elemental diets in pediatric Crohn's disease
- Effect of biologic therapy on the microbiome in IBD patients
- How internet based information affect willingness to accept prescribed therapies
Mount Sinai School of Medicine
Degree: Inflammatory Bowel Disease Research Fellowship
University of California, San Diego
Degree: Chief Medical Resident
Honors and awards
National Center for Research Resources award
- Hudesman D, Mazurek J, Swaminath A. Capsule Endoscopy in Crohn’s Disease: Are we seeing any better? World Journal of Gastroenterology 2014 Sept 28; 20(36): 13044-13051.
- Swaminath A. The Power of Poop: patients getting ahead of their physicians in fecal transplantation. American Journal of Gastroenterology 2014, 109; 777-778.
- Longman RA, ... Swaminath, A, Miraldi E, Scherl E, Littman D. Microbiota Regulate CX3CR1+ Mononuclear Phagocytes to support Colitis-Associated Innate Lymphoid Cell Production of IL-22. The Journal of Experimental Medicine 2014 Jul 28;211(8):1571-83.
- Swaminath A, Bhadelia N, Wang C. Cost-Effectiveness of QuantiFERON prior to initiation of biologic therapy in inflammatory bowel disease. Inflammatory Bowel Disease Journal 2013, Aug 13.
- Swaminath A, Lebwohl B, Capiak K, Present D. Practice patterns in the use of anti-tumor necrosis factor alpha agents in the management of Crohn’s disease: A U.S. national practice survey comparing experts and non-experts. Digestive Diseases & Sciences. 2011 Apr 56(4):1160-64.